In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors
- 1 November 2000
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 100 (3) , 195-209
- https://doi.org/10.1016/s0049-3848(00)00333-9
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Clinical applications of new antithrombotic agentsAnnals of Hematology, 1996
- New Anticoagulant StrategiesDrugs, 1994
- Direct thrombin inhibitors in cardiovascular medicine.Circulation, 1994
- Current trends in the development of anticoagulant and antithrombotic drugsMedical Clinics of North America, 1994
- The development of hirudin as an antithrombotic drugThrombosis Research, 1994
- HIRUDIN: Clinical Potential of a Thrombin InhibitorAnnual Review of Medicine, 1994
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood PlateletsNature, 1967